<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

Lisa Mahan

20+ years' experience in orthopedic industry, including 12 years at J&J DePuy Orthopaedics. Competitive Intelligence Analyst and e-Marketing manager at J&J DePuy Orthopaedics.

Recent Posts

2 min read

Total Joints Market 2024: Trends to Watch

By Lisa Mahan on 1/23/24 9:30 AM

Forces likely to influence the Total Joints Market in 2024

Final Q423 US Total Joints Market results are expected to solidify above pre-COVID growth rates for 2023. The post-pandemic patient backlog sustained strong market performance in 2023 despite tough comparisons and a challenging economic environment with rising inflation and the threat of a recession looming over healthcare consumers. What will the future hold? In this article, SmartTRAK looks at some of the trends to watch in 2024, including:

  • Mixed Predictions Regarding Patient Backlog
    Several Companies including Zimmer Biomet are banking on the backlog of patients to continue boosting procedure growth through 2024. Wall Street analysts, however, are more tempered in their forward-looking projections.
  • US Economic Factors Buoying Consumer Confidence
    The demand for health care is typically more resilient in the face of weaker economic conditions. However, improvements in some economic conditions in the US during 2024 are expected to buoy consumer confidence.
  • Ongoing Shift to Outpatient Site-of-Care Despite Reimbursement Decline
    Eligible patients are continuing to choose joint replacement surgery in an outpatient or ambulatory surgery center (ASC) setting in increasing numbers. New ASCs springing up around the country are giving potential patients expanded site-of-care options.
  • Ongoing Influence of ASC Economics
    ASCs facing lower reimbursement rates compared to hospital outpatient and inpatient settings will continue to look for product solutions that improve efficiency and reduce the overall cost of care.
  • New Product Launches to Watch
    New and early-stage hip and knee product launches for both large and mid-tier Joint Replacement Market players will drive revenue growth.

Just click the button below to download and read the complete "Total Joints 2024 Trends to Watch" market outlook article and analysis by Lisa Mahan, SmartTRAK's VP Product Development & IT, Sr. Analyst TJ&E. Read the Article
SmartTRAK
is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK offers and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
Continue Reading
3 min read

Anika's Expanding Shoulder Preservation Solutions

By Lisa Mahan on 10/31/23 9:33 AM

Anika’s President and CEO Cheryl Blanchard, Ph.D., discusses the Company’s expanding portfolio of shoulder preservation solutions

Anika Therapeutics entered the Reverse Shoulder Market this year with the US market release of the RevoMotion Reverse Shoulder Arthroplasty System, expanding their complement of products for shoulder joint preservation and replacement. This new offering allows the Company to compete in the rapidly growing US Market for Reverse Shoulders. Lisa Mahan, SmartTRAK Senior Analyst Total Joints & Extremities, talked with Cheryl Blanchard, PhD, President and CEO of Anika, to discuss the launch of RevoMotion, along with the X-Twist Fixation System, Integrity Patch System, Cingal next generation OA injectable and Tactoset Injectable Bone Substitute.
 
The Interview
 

SmartTRAK: RevoMotion has been out almost nine months now in limited release and you just went to full market release. Congratulations. How is that going?

Cheryl Blanchard: Thank you! Anika announced the full market release of the RevoMotion Reverse Shoulder Arthroplasty System (RSA) during the 2023 Orthopaedic Summit (OSET) Annual Meeting September 20-23 in Boston, MA and the response has been overwhelmingly positive.

We began the limited launch in January 2023 and have performed over 100 cases since then. The feedback we received and the response during the limited market release was impressive as some of the first patients in have already returned to their surgeons and asked for the same implant to be placed in their other shoulder. To have patients far enough into recovery to want the RevoMotion RSA in their other shoulder says a lot about the system and its future success. The limited release allowed us to collect feedback to better optimize the instrumentation and surgical technique for the full market release as well. Though we finished gathering feedback months ago, manufacturing instrument sets and system components takes time. That brought us right to our full market release during OSET in September.

We know that the reverse shoulder market is a crowded space. Given that probably 80% of the market is reverse shoulders, for Anika we knew we had something incredible to offer clinicians and patients based on the historic Arthrosurface design philosophies focused on bone sparing, motion preservation and anatomic design features. We also knew that with the data-backed and trusted OVOMotion with Inlay Glenoid Total Shoulder Arthroplasty System, it would be difficult to penetrate the full shoulder arthroplasty market without having a reverse option.

Additionally, there is a big shift of a lot of these products and procedures into the ASC setting. We will possibly see even more products coming into the ASC when CMS changes how they reimburse and we realized that there was a real opportunity to provide optimized instrument trays that would reduce the operating room footprint. RevoMotion has a two-tray instrumentation system that is very streamlined. The surgical technique is also very streamlined. We're hearing great feedback on it and we're excited to be in full market release coming into the fourth quarter.

That's wonderful. You mentioned the instrument trays and some of the design. If there was one thing that differentiates RevoMotion from other reverse shoulders on the market, what would you say that is?

CB:We believe and continue to hear feedback from surgeon users that having the smallest threaded glenoid base plate on the market is one of the biggest differentiators. Personally, I didn't understand the true significance of that until I started to speak directly with surgeons who had used the system. Listening to real-time feedback and observing in the OR, you realize it's a major benefit as it provides...

To download and read the complete transcript of the interview with Anika’s President & CEO Cheryl Blanchard conducted by Lisa Mahan, VP Product Development & IT, Sr. Analyst TJ&E, just click the button below. Download the Transcript

Continue Reading
1 min read

Trends Potentially Impacting the Total Joints Market: A Flash Report

By Lisa Mahan on 10/18/23 8:03 AM

SmartTRAK takes a quick look at recent trends that may influence the Total Joints Market in the near and long term

Wall Street Analysts recently called out two trends specifically that could influence the Total Joints Market. One trend, the strengthening of the US dollar, is likely to impact the global market in 2024. Another trend is the increased prescribing of GLP-1 drugs, such as Ozempic, Wegovy, Byetta and Mounjaro, medications first used to treat Type 2 diabetes, as a treatment for obesity. This has the potential to impact the market down the road. In this downloadable article, SmartTRAK maps out the potential impact of these trends.

To download and read the complete article by SmartTRAK's Lisa Mahan, Product Development & IT, Sr. Analyst TJ&E, just click the button below. Read the Article

Continue Reading
2 min read

Sowing the Seeds for Growth: Q123 Extremities Market Recap

By Lisa Mahan on 6/16/23 9:30 AM

New products and technologies in Shoulder Replacement and the Extremities Fixation Segments planted the seeds for sequential growth in the Q123 Extremities Market

The US Extremities Market grew 7.8% in Q123 with new products and continued recovery of elective procedures encouraging growth despite concerns about a looming recession. While headwinds such as supply chain constraints, economic challenges and staffing shortages could darken the forecast, SmartTRAK expects the Extremities Market to weather these issues and continue to experience strong growth through 2023.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Extremities Market Recap* are:

  • Complete Q123 Extremities Market Overview
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • New Products and Technologies That are Planting the Seeds for Growth in Shoulders
  • Extremities Fixation Closes the Quarter on High with Solid Returns
  • Q123 Regulatory Highlights

Both US Extremities Fixation subsegments, Upper Extremities Fixation and Foot Ankle Fixation, ended the first quarter of 2023 with ...

Read the entire Q123 Extremities Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. Learn More about Subscribing to SmartTRAK

Continue Reading
2 min read

Favorable Winds of Change: Q123 Total Joints Market Recap

By Lisa Mahan on 6/8/23 9:30 AM

Increased elective procedure volume recovery lifts market growth to new heights

The winds of change precipitated a strong season of growth for the Total Joints Market. Company after company reported increasing elective procedural volume recovery due to the underlying post-COVID demand. Procedure momentum and easier year-over-year comparisons drove market growth above double-digits with the US Total Joints Market growing +14.5% in Q123. Easing of staffing headwinds and normalization of surgery cancellation rates were also contributing factors to accelerating procedures.
 

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Total Joints Market Recap* are:

  • Complete Q123 Total Joints Market Overview
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • Technologies and Procedure Recovery Elevating Hip Growth
  • The Ongoing March Towards Cementless Knees
  • Deals and Financing Highlights
  • Q123 Regulatory Highlights

Will this momentum continue throughout 2023? SmartTRAK believes underlying demand for hip and knee replacement surgery will ...

Read the entire Q123 Total Joints Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. Learn More about Subscribing to SmartTRAK

Continue Reading
2 min read

New Products, Strong Growth & Continuing Strength: Q422 Extremities Market Recap

By Lisa Mahan on 4/24/23 10:02 AM

Strong growth across market segments and new products coming to market signal continuing Extremities Market strength

SmartTRAK reports that the Q422 WW Extremities Market, WW Upper Extremities Market, WW Foot & Ankle Market, US Extremities Market, US Upper Extremities Market and the US Foot & Ankle Market were all up between +4.5% and +9.0% YoY.
 

Among the many topics covered in detail in SmartTRAK's comprehensive Q422 Extremities Market Recap* are:

  • Complete Q422 Extremities Market Overview and Highlights
  • SmartTRAK's Expert Market Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • New Shoulder Products Driving Growth with More Tech Updates Coming
  • Ankle Market Poised for Expansion with Next-Generation Implants and Technology
  • Renewed Manufacturer Focus along with New Product Intros Fuel Upper Extremities Fixation
  • Foot & Ankle Fixation Propelled by New Product Introductions
  • Q422 Regulatory Highlights
    • Fixation
    • Shoulder Replacement
    • Elbow Replacement
    • Ankle Replacement
    • Toe Replacement
Read the entire Q422 Extremities Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.Learn More about Subscribing to SmartTRAK
Continue Reading
2 min read

AAOS 2023: Total Joint Viewpoint

By Lisa Mahan on 3/27/23 11:00 AM

AAOS approaches “Next to Normal” as surgeons and industry focus on solutions to meet the needs of patients returning to joint replacement

If an ad agency had branded the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting this year, the tagline would have read “Getting back to normal.” Surgeons toured the exhibit hall throughout the day not just during dedicated hours. The meeting felt as if it had come back to life with industry symposiums and conference presentations often seeing standing-room-only crowds when a few years ago even the exhibit floor felt like a ghost town. And while some of the large orthopedic companies slightly scaled down their booth space, several mid-tier and small market players increased their presence at the meeting in an attempt to pique surgeon interest. So what was the buzz at AAOS 2023 related to hip and knee replacement? In this article, SmartTRAK outlines some of the key takeaways, including: 
  • Procedure Recovery May Signal Return of Deferred Procedures
    • Both clinicians and company representatives at the meeting revealed to SmartTRAK that they are seeing increased hip and knee procedure volumes heading into 2023. The overall consensus was ...

  • The Move to Outpatient Joint Replacement Continues.
    • Data presented at AAOS 2023 continues to support the move of joint replacement surgeries to an outpatient setting. A study focusing on patient satisfaction after outpatient joint replacement in an academic medical center reported ...

  • Cementless Knee Trend Growing Despite Mixed Results
    • Clinical evidence presented at AAOS showed mixed results for cementless total knees with some studies reporting excellent outcomes and others identifying increased risks associated with ...

  • Assistive Technologies Growing and Evolving
    • Assistive technology presentations and booth exhibits seemed to generate the most interest at AAOS 2023. Elise Wolf, SmartTRAK’s assistive technologies expert, noted the most innovative products and ...

To download and read the complete "AAOS 2023: Total Joint Viewpoint" article by SmartTRAK's Lisa Mahan,  VP Product Development & IT, Sr. Analyst TJ&E, just click the button below. Download the AAOS 2023 Article

Continue Reading
2 min read

Strong Revenue Growth: Q422 Total Joints Market Highlights

By Lisa Mahan on 3/24/23 9:42 AM

Procedure recovery above Q4 seasonality, new products and assistive tech push strong revenue growth

  For Q422, the US Hip Replacement Market grew +8.4% according to SmartTRAK Financial Dashboard . Newer products, implant pull-through from assistive technologies and procedure recovery continued to positively impact growth. Nearly all companies in our reporting universe cited procedure recovery as a growth driver.
 
The US Knee Replacement Market grew +9.3% in Q422, driven in part by knee procedure recovery. Recovery appeared to be above that of the typical year-end seasonality of patients trying to fit in surgery before insurance deductibles reset. SmartTRAK has heard rumblings that the growth seen in Q4 may be a sign that ...
 

To read more about the strong revenue growth in the Total Joints Market, including Procedure Recovery, New Products and Assistive Technologies Driving Growth in the Hip Market and Cementless Knees and Enabling Tech Expanding the Knee Market, just click the link below.

 
* This link and the complete unedited article can only be viewed by SmartTRAK  subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please  click  the button below.Learn More about Subscribing to SmartTRAK
Continue Reading
2 min read

Total Joints Trends Heading Into 2023

By Lisa Mahan on 2/27/23 9:00 AM

SmartTRAK examines conditions lowering the flame for Total Joints

Procedural growth strengthened in 2022 giving rise to the hope that a backlog of patients created by the COVID pandemic would return to surgery, stoking the fires of Total Joint Market recovery. However, external market forces appear to be setting the market to simmer in 2023 while other forces influence the recipe for success for market players.
 
An analyst from JP Morgan has  drawn  parallels between the current behavior of the US stock and bond markets and the conditions leading up to the 1969 recession, according to a recent  Forbes  article. Interest rate hikes and high inflation have increased the likelihood that the US economy will face a recession in 2023. But what does that mean for the Total Joints Market?
 

Among the many topics covered in detail in this comprehensive article are:

Continue Reading
2 min read

2023 Extremities Trends to Watch

By Lisa Mahan on 2/21/23 12:17 PM

SmartTRAK highlights trends affecting the US Extremities Market in 2023

The Extremities Market continues to be a hotbed of activity heading into 2023. SmartTRAK highlights trends that will continue to affect the US Market for Extremities in 2023, including CMS reimbursement obstacles, new product introductions and potential mergers and acquisitions.
 

Among the many topics covered in detail in this comprehensive article are:

  • SmartTRAK's Expert Market Analysis and Insights
  • Outpatient Shoulder Replacement Growing Despite Lack of CMS Reimbursement
  • New Shoulders May Heat Up Competition
  • New Ankle Products and Technologies May Boost Growth
  • New Products, DTC and Potential M&As Heat Up Extremities Fixation
  • M&As on the Horizon

To download and read the complete "2023 Extremities Trends to Watch" article, just click the button below.Download the Extremities Trends Article

The countdown to AAOS 2023 on March 7-11 in Las Vegas has begun and the SmartTRAK team will be attending...see you there!

Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles